GlassScriptPhysician profile
Harold Steven Coss
NPI 1851391312
$11,681.00
in general payments reported to CMS, 2019-2025
21 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,466 · 2020: $778 · 2021: $1,638 · 2022: $719 · 2023: $1,978 · 2024: $1,791 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,080 · Travel and Lodging: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,079.54 |
| Travel and Lodging | $1,999.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,240.31 | 2019-2024 | |
| Rock Medical Orthopedics, INC. | $2,204.04 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $1,216.37 | 2019-2025 | Rosa, Identity, Mymobility Platform |
| Smith+Nephew, INC. | $168.84 | 2019-2022 | |
| Pacira Therapeutics, INC. | $160.59 | 2019-2021 | |
| Integra Lifesciences Corporation | $136.38 | 2022 | |
| Stryker Corporation | $103.92 | 2022-2025 | Alphavent |
| Vericel Corporation | $102.59 | 2022-2024 | Maci |
| Vertex Pharmaceuticals Incorporated | $91.35 | 2024-2025 | |
| Theragen, INC. | $54.21 | 2024 | Actastim-S |
| Convatec INC. | $32.75 | 2022-2025 | Aquacel Ag Surgical |
| Ferring Pharmaceuticals INC. | $25.90 | 2019-2025 | Euflexxa |
| Orthofix Medical, INC. | $22.29 | 2019 | |
| Endo USA, INC. | $21.00 | 2025 | Xiaflex |
| Bioventus LLC | $19.89 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $17.45 | 2019 | |
| Depuy Synthes Sales INC. | $13.59 | 2025 | Monovisc |
| Acelrx Pharmaceuticals, INC. | $13.20 | 2021 | |
| Medline Industries LP | $12.63 | 2019 | |
| Boston Scientific Corporation | $12.25 | 2022 | |
| Endo Pharmaceuticals INC. | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Coss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.